BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 20232325)

  • 1. Locked nucleic acids: promising nucleic acid analogs for therapeutic applications.
    Veedu RN; Wengel J
    Chem Biodivers; 2010 Mar; 7(3):536-42. PubMed ID: 20232325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic oligonucleotides.
    Goodchild J
    Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
    Vester B; Wengel J
    Biochemistry; 2004 Oct; 43(42):13233-41. PubMed ID: 15491130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LNA-antisense rivals siRNA for gene silencing.
    Jepsen JS; Wengel J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locked nucleic acid nucleoside triphosphates and polymerases: on the way towards evolution of LNA aptamers.
    Veedu RN; Wengel J
    Mol Biosyst; 2009 Aug; 5(8):787-92. PubMed ID: 19603111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in locked nucleic acid research].
    Li SM; Xu X; Liang HP; Li L
    Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):319-23. PubMed ID: 14992013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locked nucleic acid as a novel class of therapeutic agents.
    Veedu RN; Wengel J
    RNA Biol; 2009; 6(3):321-3. PubMed ID: 19458498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.
    Orum H; Wengel J
    Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide.
    Fluiter K; Frieden M; Vreijling J; Rosenbohm C; De Wissel MB; Christensen SM; Koch T; Ørum H; Baas F
    Chembiochem; 2005 Jun; 6(6):1104-9. PubMed ID: 15861430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity and biotechnological aspects of locked nucleic acids.
    Lundin KE; Højland T; Hansen BR; Persson R; Bramsen JB; Kjems J; Koch T; Wengel J; Smith CI
    Adv Genet; 2013; 82():47-107. PubMed ID: 23721720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclease resistant methylphosphonate-DNA/LNA chimeric oligonucleotides.
    Nagahama K; Veedu RN; Wengel J
    Bioorg Med Chem Lett; 2009 May; 19(10):2707-9. PubMed ID: 19375912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality.
    Elmén J; Thonberg H; Ljungberg K; Frieden M; Westergaard M; Xu Y; Wahren B; Liang Z; Ørum H; Koch T; Wahlestedt C
    Nucleic Acids Res; 2005; 33(1):439-47. PubMed ID: 15653644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of affinity constants of locked nucleic acid (LNA) and DNA duplex formation using label free sensor technology.
    Möhrle BP; Kumpf M; Gauglitz G
    Analyst; 2005 Dec; 130(12):1634-8. PubMed ID: 16284662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energetic aspects of locked nucleic acids quadruplex association and dissociation.
    Petraccone L; Erra E; Randazzo A; Giancola C
    Biopolymers; 2006 Dec; 83(6):584-94. PubMed ID: 16944520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino.
    Karkare S; Bhatnagar D
    Appl Microbiol Biotechnol; 2006 Aug; 71(5):575-86. PubMed ID: 16683135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmer.
    Fluiter K; Mook OR; Vreijling J; Langkjaer N; Højland T; Wengel J; Baas F
    Mol Biosyst; 2009 Aug; 5(8):838-43. PubMed ID: 19603119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR studies of fully modified locked nucleic acid (LNA) hybrids: solution structure of an LNA:RNA hybrid and characterization of an LNA:DNA hybrid.
    Nielsen KE; Rasmussen J; Kumar R; Wengel J; Jacobsen JP; Petersen M
    Bioconjug Chem; 2004; 15(3):449-57. PubMed ID: 15149171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections.
    Obernosterer G; Martinez J; Alenius M
    Nat Protoc; 2007; 2(6):1508-14. PubMed ID: 17571058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LNA and alpha-L-LNA: towards therapeutic applications.
    Wengel J; Vester B; Lundberg LB; Douthwaite S; Sørensen MD; Babu BR; Gait MJ; Arzumanov A; Petersen M; Nielsen JT
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):601-4. PubMed ID: 14565236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on chemistry and therapeutic applications of Locked Nucleic Acid (LNA).
    Kaur H; Babu BR; Maiti S
    Chem Rev; 2007 Nov; 107(11):4672-97. PubMed ID: 17944519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.